Publisher： Bentham Science Publishers
E-ISSN： 1873-5576|18|4|306-327
ISSN： 1568-0096
Source： Current Cancer Drug Targets, Vol.18, Iss.4, 2018-04, pp. : 306-327
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Protein tyrosine kinase inhibitors in cancer treatment
By Traxler P.M.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. :
Access to resources
Recommend
Tyrosine kinase inhibitors in cancer treatment (Part II)
By Traxler P.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. :
Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. :
Overcoming Treatment Resistance in HER2-Positive Breast Cancer: Potential Strategies
By Puglisi Fabio >
Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. :